ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1136

Injured Epithelia with Nuclear Factor kB Activation Drives Renal Fibrosis by Remodeling the Fibrotic Microenvironment

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Author

  • Hou, Yanjuan, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Group or Team Name

  • Susztak Lab.
Background

Tubular epithelial injury significantly influences chronic kidney disease (CKD) progression. A subset of injured proximal tubule cells (iPT), characterized by markers Vcam1 and Kim1, has been observed in both acute and chronic kidney diseases and appears to play a crucial role in promoting fibrosis by remodeling the renal microenvironment. However, the transcription factors driving iPT-mediated fibroinflammatory reprogramming remain unclear.

Methods

We integrated cross-species single-cell and spatial transcriptomic datasets from human, rat, and mouse kidneys to identify conserved signaling pathways in iPT cells. CUT&RUN profiling of four key NF-κB subunits (NF-κB1, RelA, NF-κB2, RelB) was performed on primary tubular cells. Functional validation was conducted in RPTEC cultures stimulated with injury-related cytokines (e.g., IFN-γ/TNF-α), followed by pharmacologic inhibition and CRISPR interference. The specific contribution of each subunit was assessed using Sox9+ -targeted conditional knockout models (Sox9CreERT2-Nfkb1f/f, -RelAf/f, -Nfkb2f/f, -RelBf/f) subjected to adenine-induced CKD.

Results

NF-κB pathway activation emerged as a conserved transcriptional signature in iPT cells across species. In vitro, IFN-γ/TNF-α synergistically induced NF-κB activation and a profibrotic-inflammatory phenotype mimicking iPT cells. Integrated CUT&RUN, scRNA-seq, and scATAC-seq analyses identified the NF-κB2/RelB axis as most closely associated with the iPT transcriptional program. Among the four NF-κB subunits, conditional deletion of Nfkb2 in Sox9+ tubular cells most effectively reduced iPT cell expansion and mitigated fibroinflammation, outperforming RelA and RelB deletion. Further analysis revealed that NF-κB2 orchestrates a transcriptional network that promotes epithelial reprogramming and fibrotic niche remodeling.

Conclusion

These findings identify NF-κB2 as the key NF-κB subunit driving fibroinflammatory reprogramming in injured tubular epithelium, highlighting its potential as a targeted therapeutic strategy in CKD. Targeting NF-κB2-driven pathways may significantly alter the trajectory of fibrosis development, offering critical insights into novel treatment approaches for kidney disease.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)